Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,233
Closed -$111K 273
2024
Q4
$111K Sell
1,233
-156
-11% -$12.5K 0.06% 244
2024
Q3
$86.3K Buy
1,389
+1,359
+4,530% +$76.2K 0.05% 248
2024
Q2
$1.6K Buy
30
+20
+200% +$1.13K ﹤0.01% 764
2024
Q1
$596 Sell
10
-759
-99% -$42.9K ﹤0.01% 828
2023
Q4
$45.7K Buy
769
+759
+7,590% +$34.8K 0.03% 308
2023
Q3
$420 Sell
10
-3,510
-100% -$172K ﹤0.01% 641
2023
Q2
$180K Buy
3,520
+1,000
+40% +$53K 0.16% 125
2023
Q1
$147K Buy
2,520
+22
+0.9% +$1.31K 0.13% 144
2022
Q4
$138K Buy
2,498
+77
+3% +$3.75K 0.13% 141
2022
Q3
$129K Buy
2,421
+2,417
+60,425% +$152K 0.12% 154
2022
Q2
$981 Sell
4
-2,338
-100% -$189K ﹤0.01% 692
2022
Q1
$250K Buy
+2,342
New +$269K 0.16% 134

Other funds holding DOCU

Castleview Partners's DOCU Position: Q1 2025 in Review

Castleview Partners sold out of DocuSign (DOCU) in Q1 2025, closing a stake of 1,233 shares — an estimated $111K sold.

Castleview Partners first reported a position in DOCU in Q1 2022 and held it in 12 quarters. The position peaked at $250K in Q1 2022. 810 funds tracked by Wall St. Rank hold DOCU as of Q1 2025.

  • Castleview Partners reported no remaining DocuSign position as of Q1 2025 after selling out during the quarter.
  • Castleview Partners sold 1,233 DocuSign shares in Q1 2025, an estimated $111K.
  • Castleview Partners first reported a position in DocuSign in Q1 2022 and held it in 12 quarters.
  • Castleview Partners's DocuSign position peaked at $250K in Q1 2022.
  • 810 funds tracked by Wall St. Rank held DocuSign as of Q1 2025.

Based on Castleview Partners's 13F filing for Q1 2025, filed 22 Apr 2025.